Aeterna Zentaris to Present at the 2017 BIO CEO and Investor Conference
February 07 2017 - 04:15PM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”)
today announced that it will be presenting at the 2017 BIO CEO
& Investor Conference on Monday, February 13 at 8:00 AM EST in
New York City. President and Chief Executive Officer, Mr. David A.
Dodd will be presenting an updated Company overview, as well as
meeting with investors.
Participants may access the live webcast via the Company's
website at www.aezsinc.com. A replay of the webcast will also be
available on the Company’s website approximately one hour following
the live webcast.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology and endocrinology. We are engaged in drug development
activities and in the promotion of products for others. We are now
conducting Phase 3 studies of two internally developed compounds.
The focus of our business development efforts is the acquisition or
in-license of products that are relevant to our therapeutic areas
of focus. We also intend to license out certain commercial rights
of internally developed products to licensees in territories where
such out-licensing would enable us to ensure development,
registration and launch of our product candidates. Our goal is to
become a growth-oriented specialty biopharmaceutical company by
pursuing successful development and commercialization of our
product portfolio, achieving successful commercial presence and
growth, while consistently delivering value to our shareholders,
employees and the medical providers and patients who will benefit
from our products. For more information, visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170207006179/en/
Aeterna Zentaris Inc.Philip A. Theodore, 843-900-3223Senior Vice
PresidentIR@aezsinc.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Mar 2023 to Mar 2024